50-32-203. Effect of rescheduling under federal law. If any drug is designated, rescheduled, or deleted as a "controlled substance" under federal law and notice thereof is given to the board, the board shall similarly control the drug under this chapter after the expiration of 30 days from publication in the Federal Register of a final order designating a drug as a "controlled substance" or rescheduling or deleting a drug unless, within that 30-day period, the board objects to inclusion, rescheduling, or deletion. In that case, the board shall cause the reasons for objection to be published and afford all interested parties an opportunity to be heard. At the conclusion of the hearing, the department shall publish the board's decision which shall be final unless altered thereafter by the board or by statute. Upon publication of objection to inclusion, rescheduling, or deletion under this chapter by the board, control under this chapter is stayed until the board's decision is published.
History: En. Sec. 2, Ch. 412, L. 1973; amd. Sec. 2, Ch. 350, L. 1974; R.C.M. 1947, 54-302(4).
Structure Montana Code Annotated
Chapter 32. Controlled Substances
Part 2. Scheduling of Dangerous Drugs
50-32-201. General criteria to be considered
50-32-202. Designation of drug as dangerous drug
50-32-203. Effect of rescheduling under federal law
50-32-204. Immediate precursors
50-32-205. Nonprescription drugs not to be scheduled
50-32-206. Use of names of scheduled drugs
50-32-207. Order forms for drugs in Schedules I and II
50-32-208. Prescription and medical requirements for scheduled drugs -- penalty
50-32-209. Republication of schedules
50-32-210. through 50-32-220 reserved
50-32-221. Criteria for placement of drug in Schedule I
50-32-222. Specific dangerous drugs included in Schedule I
50-32-223. Criteria for placement of drug in Schedule II
50-32-224. Specific dangerous drugs included in Schedule II
50-32-225. Criteria for placement of drug in Schedule III
50-32-226. Specific dangerous drugs included in Schedule III
50-32-227. Board authorized to exempt certain compounds, mixtures, or preparations from Schedule III
50-32-228. Criteria for placement of drug in Schedule IV
50-32-229. Specific dangerous drugs included in Schedule IV
50-32-230. Board authorized to exempt certain compounds, mixtures, or preparations from Schedule IV
50-32-231. Criteria for placement of drug in Schedule V